CURIS, INC. Accounts Payable
CURIS, INC. (CRIS) had Accounts Payable of $5.39 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-14
- 2026-06-30: Accounts Payable, Current $5.39M.
- 2026-03-31: Accounts Payable, Current $6.74M.
- 2025-12-31: Accounts Payable, Current $5.61M.
- 2025-09-30: Accounts Payable, Current $4.45M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $5.39M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $6.74M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $5.61M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $4.45M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $4.10M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $5.10M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $3.02M 10-K · filed 2026-03-24 | |
| 2024-09-30 | $3.82M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $2.45M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $3.63M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $3.17M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $5.22M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $2.69M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $2.64M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $3.19M 10-K · filed 2024-02-08 | |
| 2022-09-30 | $5.76M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $5.51M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $4.28M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $6.42M 10-K · filed 2023-03-13 | |
| 2021-09-30 | $3.51M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $4.05M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $3.43M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $4.17M 10-K · filed 2022-02-24 | |
| 2020-09-30 | $4.32M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $4.96M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $4.27M 10-Q · filed 2020-05-12 | |
| 2019-12-31 | $4.46M 10-K · filed 2021-03-16 | |
| 2019-09-30 | $2.48M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $2.16M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $2.33M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $2.91M 10-K · filed 2020-03-19 | |
| 2018-09-30 | $3.01M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $4.28M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $5.12M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $5.42M 10-K · filed 2019-03-26 | |
| 2017-09-30 | $6.52M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $8.20M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $5.91M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $5.88M 10-K · filed 2018-03-08 | |
| 2016-09-30 | $5.06M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $3.88M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $4.87M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $4.22M 10-K · filed 2017-03-09 | $4.22M 10-K · filed 2016-02-29 |
| 2015-09-30 | $2.57M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $2.39M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $2.78M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $2.35M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $2.37M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $2.85M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $2.55M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $2.04M 10-K · filed 2015-02-24 | |
| 2013-09-30 | $2.29M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $2.58M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $2.17M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $2.50M 10-K · filed 2014-03-13 | |
| 2012-09-30 | $2.69M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $2.43M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $2.64M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $2.36M 10-K · filed 2013-03-13 | |
| 2011-09-30 | $2.33M 10-Q · filed 2011-10-31 | |
| 2011-06-30 | $2.69M 10-Q · filed 2011-08-04 | |
| 2010-12-31 | $2.62M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |